Save time and jump to the most important pieces.
Dawson James initiated coverage of SRAX with a rating of Buy and set a new price target of $10.00
B. Riley reiterated coverage of SRAX with a rating of Buy and set a new price target of $7.50 from $4.50 previously
Ladenburg Thalmann initiated coverage of SRAX with a rating of Buy and set a new price target of $7.00
For Immediate Release: June 07, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: Today, the FDA announced that it has advised the manufacturers of the licensed and authorized COVID-19 vaccines that the COVID-19 vaccines (2024-2025 Formula) for use in the United States should be monovalent (single strain) JN.1 vaccines to more closely match cu
For Immediate Release: March 22, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: Today, the FDA issued an emergency use authorization for Pemgarda (pemivibart) for the pre-exposure prophylaxis (prevention) of COVID-19 in certain adults and adolescents (12 years of age and older weighing at least 40 kilograms [about 88 pounds]). Pemgarda is
For Immediate Release: November 09, 2023 Today, the U.S. Food and Drug Administration approved Adzynma, the first recombinant (genetically engineered) protein product indicated for prophylactic (preventive) or on demand enzyme replacement therapy (ERT) in adult and pediatric patients with congenital thrombotic thrombocytopenic purpura (cTTP), a rare and life-threatening blood clotting disorder. “The FDA remains
10-Q - Freedom Holding Corp. (0000924805) (Filer)
8-K - Freedom Holding Corp. (0000924805) (Filer)
10-K - SRAX, Inc. (0001538217) (Filer)
For Immediate Release: June 07, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: Today, the FDA announced that it has advised the manufacturers of the licensed and authorized COVID-19 vaccines that the COVID-19 vaccines (2024-2025 Formula) for use in the United States should be monovalent (single strain) JN.1 vaccines to more closely match cu
Los Angeles, California--(Newsfile Corp. - March 20, 2023) - SRAX, Inc. (NASDAQ:SRAX), a leading financial technology company, has announced the appointment of Alan Urban as the CFO of SRAX. Mr. Urban has over 30 years of experience in corporate finance and accounting. He has previously served in numerous senior management positions, most notably as Chief Financial Officer for ten years at Research Solutions, a provider of SaaS solutions for life science organizations. Mr. Urban also serves on the Board of Directors of GT Biopharma."We are excited to have Alan step into this very important role at SRAX. We believe his 30 years of expertise will be instrumental in getting our accounting t
Citigroup Veteran Named Freedom Executive Vice President Appointment Recognizes Leadership and Contributions to Future Growth Freedom Capital Markets (FCM), the investment banking and equity capital markets arm of Prime Executions, Inc., a wholly-owned subsidiary of Freedom Holding Corp. (NASDAQ:FRHC) is pleased to announce the appointment of Citigroup veteran Jon V. Rogers as Executive Vice President and a member of FCM's Management and Investment Committees. "Jon will play a pivotal role in all strategic initiatives as we continue to expand Freedom's U.S. footprint and offerings. His experience analyzing equity transactions at Citi will also be very beneficial as we build out our inves
4 - Freedom Holding Corp. (0000924805) (Issuer)
4 - Freedom Holding Corp. (0000924805) (Issuer)
4 - Freedom Holding Corp. (0000924805) (Issuer)
Company Reports Record Year, With 105% Increase in Reported RevenuesALMATY, KAZAKHSTAN / ACCESSWIRE / June 14, 2024 / Freedom Holding Corp. (NASDAQ:FRHC) ("Freedom", or the "Company"), a multi-national diversified financial services holding company with a presence through its subsidiaries in 20 countries, today announced its financial results for the 12 months ended March 31, 2024, or fiscal 2024. Fiscal 2024 Highlights:Revenue totaled approximately $1.6 billion compared to $796 million for the prior fiscal year, an increase of 105%, primarily attributable to an increase in interest income, fee and commission income, and insurance underwriting income.Fee and commission income was $440 mill
Company Reports Record Year, With 105% Increase in Reported Revenues Freedom Holding Corp. (NASDAQ:FRHC) ("Freedom", or the "Company"), a multi-national diversified financial services holding company with a presence through its subsidiaries in 20 countries, today announced its financial results for the twelve months ended March 31, 2024, or fiscal 2024. Commenting on the results, Timur Turlov, the Company's founder and chief executive officer, stated: "I am pleased to report that fiscal 2024 has been a record year for our company, both from a revenue and earnings perspective. Our core brokerage and banking businesses constituted approximately 75% of our revenue for the period and we c
Purchase Will Bring e-Commerce Grocery Sales to the Freedom Group Freedom Holding Corp. (NASDAQ:FRHC), a diversified multi-national financial services firm, today announced that it has completed the acquisition of an 82% ownership interest in Kazakhstan company "Arbuz Group" Limited Liability Partnership ("Arbuz") from a group of private investors. The acquisition took place in several stages starting in March 2023. Arbuz is an online supermarket and fresh food delivery service with operations in Almaty and Astana, Kazakhstan. It has become a flagship marketplace in Kazakhstan's food-tech industry. "As one of the largest domestic Internet websites in Kazakhstan, the Arbuz startup is a
SC 13G/A - SRAX, Inc. (0001538217) (Subject)
SC 13G/A - SRAX, Inc. (0001538217) (Subject)
SC 13G/A - SRAX, Inc. (0001538217) (Subject)
Class action attempts since late 2023 and a Russian court seizing $21 million of billionaire CEO Timur Turlov's assets kept Freedom Holding bearish so far. Momentum indicators have massively improved, and solid earnings could move the stock closer to the MSCI emerging market index this summer. When one thinks of emerging market stocks, few consider that faraway Central Asian nation, Kazakhstan, the place billionaire Timur Turlov calls home. But this year, a Kazakh e-commerce platform called Kaspi.Kz (KSPI) made its debut on the Nasdaq at $95.97 a share on January 19. It reached a peak of $135.14 and is now around $118 per share with a 6.16% dividend yield; unheard of for most new tech s
Most of the World's Top Chess Players Compete in Electrifying Rapid Format for the Most Thrilling Chess Event of the Year One of the most popular and prestigious chess tournaments held by the International Chess Federation (FIDE), the World Rapid & Blitz, will be held in North America for the first time ever. The championship, attracting 300 of the best players from around the world, will take place in New York City's financial district on December 26-31, 2024. This six-day event will showcase elite chess players from every continent as they converge on the heart of Wall Street. A prize fund of nearly $1.5 million will be presented at the tournament. Freedom Holding Corp. (NASDAQ:FRHC),
A Record Quarter for the Company with $581 Million in Revenue ReportedALMATY, KAZAKHSTAN / ACCESSWIRE / November 8, 2024 / Freedom Holding Corp. (the "Company") (NASDAQ:FRHC), a multinational diversified financial services holding company with a presence through its subsidiaries in 22 countries, today announced the financial results for their second quarter and first six months of fiscal 2025. Highlights include the following:$581 million in revenue for the quarterNet income of $115 million, or $1.89 earnings per share, diluted, and $1.93 earnings per share, basicOperating expenses of $452 million$8.8 billion in assets at the end of the quarterInsurance underwriting segment lead revenue grow
A Record Quarter for the Company with $581 Million in Revenue Reported Freedom Holding Corp. (the "Company") (NASDAQ:FRHC), a multinational diversified financial services holding company with a presence through its subsidiaries in 22 countries, today announced the financial results for their second quarter and first six months of fiscal 2025. Highlights include the following: $581 million in revenue for the quarter Net income of $115 million, or $1.89 earnings per share, diluted, and $1.93 earnings per share, basic Operating expenses of $452 million $8.8 billion in assets at the end of the quarter Insurance underwriting segment lead revenue growth with a 121% Y.O.Y. increase Ex